Impact of Atrial Fibrillation on the Risk of Thrombosis and Bleeding for Patients With Polycythemia Vera and Essential Thrombocytosis in the Real World. [PDF]
Ortega Perez R +19 more
europepmc +1 more source
A KMT2C loss-of-function mutation in a JAK2-negative polycythemia vera-like myeloproliferative neoplasm: a case report. [PDF]
Musa TN +4 more
europepmc +1 more source
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera. [PDF]
Angona A +31 more
europepmc +1 more source
Why JAK2-mutated neutrophils deserve to be on center stage in polycythemia vera. [PDF]
Masarova L +5 more
europepmc +1 more source
Disseminated Tuberculosis Mimicking Metastatic Cancer During Ruxolitinib Therapy for Polycythemia Vera: A Case Report and Literature Review. [PDF]
Ono Y +4 more
europepmc +1 more source
Pernicious Anemia Resulting in Intramedullary Hemolysis, Masking Underlying Polycythemia Vera and Mild Alpha-Thalassemia-A Case Report. [PDF]
Rohner A +3 more
europepmc +1 more source
Multi-Compartment Transcriptomics Identifies a Persistent Inflammatory Program and a Network-Derived Diagnostic Signature in Polycythemia Vera. [PDF]
Alruwetei AM.
europepmc +1 more source
Hematologic and molecular response to ropeginterferon alfa-2b in patients with polycythemia vera: a systematic review and meta-analysis. [PDF]
Elgadi A +4 more
europepmc +1 more source
openaire +1 more source
Related searches:
THE course of polycythemia vera is complicated by hemorrhagic and thromboembolic phenomena of varying severity occurring in about a third of the cases. These complications have been ascribed to the hypervolemia and increased red-cell mass, with resultant sluggish blood flow, capillary distention with poor retractability, thrombocytosis and a complex ...
Louis R Wasserman +2 more
exaly +3 more sources

